Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study).
Hiroshi NomotoSho FurusawaAkinobu NakamuraJun TakeuchiSo NagaiHiroki YokoyamaIchiro SakumaShinji TanedaYoshio KuriharaShin AokiAika MiyaHiraku KamedaKyu Yong ChoTatsuya AtsumiHideaki MiyoshiPublished in: BMJ open (2022)
UMIN000045270 in the University Hospital Medical Information Network; jRCT1011210032 in the Japan Registry of Clinical Trials.